Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trinity Bivalacqua

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncotarget|July 2, 2014
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineLeonel Maldonado, Mariana Brait, Christina Michailidi, et al.
Urology|March 4, 2015
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinomaSheila F Faraj, Enrico Munari, Gunes Guner, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Oncotarget|May 17, 2014
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urineMasamichi Hayashi, Heike Bernert, Luciane Tsukamoto Kagohara, et al.
European Urology Oncology|April 17, 2023
Adaptive Immunity in Genitourinary CancersMadhuri Koti, Trinity Bivalacqua, Peter C Black, et al.
Journal of Surgical Oncology|March 3, 2017
Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patientsEihab Abdelfatah, Andrew Page, Justin Sacks, et al.
Cancer Research|October 15, 2013
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineIsaac Kinde, Enrico Munari, Sheila F Faraj, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think TankAshish M Kamat, Piyush Agarwal, Trinity Bivalacqua, et al.
The Journal of Urology|December 6, 2017
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter StudySiamak Daneshmand, Sanjay Patel, Yair Lotan, et al.
BJU International|July 7, 2018
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre studyAngela B Smith, Siamak Daneshmand, Sanjay Patel, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncotarget|July 2, 2014
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineLeonel Maldonado, Mariana Brait, Christina Michailidi, et al.
Urology|March 4, 2015
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinomaSheila F Faraj, Enrico Munari, Gunes Guner, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Oncotarget|May 17, 2014
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urineMasamichi Hayashi, Heike Bernert, Luciane Tsukamoto Kagohara, et al.
European Urology Oncology|April 17, 2023
Adaptive Immunity in Genitourinary CancersMadhuri Koti, Trinity Bivalacqua, Peter C Black, et al.
Journal of Surgical Oncology|March 3, 2017
Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patientsEihab Abdelfatah, Andrew Page, Justin Sacks, et al.
Cancer Research|October 15, 2013
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineIsaac Kinde, Enrico Munari, Sheila F Faraj, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think TankAshish M Kamat, Piyush Agarwal, Trinity Bivalacqua, et al.
The Journal of Urology|December 6, 2017
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter StudySiamak Daneshmand, Sanjay Patel, Yair Lotan, et al.
BJU International|July 7, 2018
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre studyAngela B Smith, Siamak Daneshmand, Sanjay Patel, et al.
Pageof 3